To test this hypothesis, we investigated the expression and chromatin-based epigenetic signature of the ERBB2 gene in epithelial-like HER2-high and mesenchymal-like HER2-low breast cancer cells. The gene discussed is ERBB2; the disease is breast carcinoma.